Annual Accounts Payable
$1.07 M
-$553.00 K-34.14%
31 December 2023
Summary:
Eterna Therapeutics annual accounts payable is currently $1.07 million, with the most recent change of -$553.00 thousand (-34.14%) on 31 December 2023. During the last 3 years, it has fallen by -$208.00 thousand (-16.31%). ERNA annual accounts payable is now -39.20% below its all-time high of $1.75 million, reached on 31 December 2021.ERNA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.19 M
$0.000.00%
30 September 2024
Summary:
Eterna Therapeutics quarterly accounts payable is currently $2.19 million, unchanged on 30 September 2024. Over the past year, it has increased by +$729.00 thousand (+49.80%). ERNA quarterly accounts payable is now -40.40% below its all-time high of $3.68 million, reached on 01 June 2021.ERNA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ERNA Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.1% | +49.8% |
| 3 y3 years | -16.3% | +120.1% |
| 5 y5 years | - | - |
ERNA Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -39.2% | at low | -18.0% | +120.1% |
| 5 y | 5 years | -39.2% | at low | -40.4% | +120.1% |
| alltime | all time | -39.2% | at low | -40.4% | +120.1% |
Eterna Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.19 M(0.0%) |
| June 2024 | - | $2.19 M(+6.3%) |
| Mar 2024 | - | $2.06 M(+93.3%) |
| Dec 2023 | $1.07 M(-34.1%) | $1.07 M(-27.1%) |
| Sept 2023 | - | $1.46 M(-45.3%) |
| June 2023 | - | $2.67 M(+83.1%) |
| Mar 2023 | - | $1.46 M(-9.8%) |
| Dec 2022 | $1.62 M | $1.62 M(+40.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $1.15 M(-22.2%) |
| June 2022 | - | $1.48 M(+33.6%) |
| Mar 2022 | - | $1.11 M(-37.0%) |
| Dec 2021 | $1.75 M(+37.6%) | - |
| Dec 2021 | - | $1.75 M(+76.2%) |
| Sept 2021 | - | $996.30 K(-72.9%) |
| June 2021 | - | $3.68 M(+103.1%) |
| Mar 2021 | - | $1.81 M(+42.1%) |
| Dec 2020 | $1.27 M | $1.27 M |
FAQ
- What is Eterna Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Eterna Therapeutics?
- What is Eterna Therapeutics annual accounts payable year-on-year change?
- What is Eterna Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Eterna Therapeutics?
- What is Eterna Therapeutics quarterly accounts payable year-on-year change?
What is Eterna Therapeutics annual accounts payable?
The current annual accounts payable of ERNA is $1.07 M
What is the all time high annual accounts payable for Eterna Therapeutics?
Eterna Therapeutics all-time high annual accounts payable is $1.75 M
What is Eterna Therapeutics annual accounts payable year-on-year change?
Over the past year, ERNA annual accounts payable has changed by -$553.00 K (-34.14%)
What is Eterna Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ERNA is $2.19 M
What is the all time high quarterly accounts payable for Eterna Therapeutics?
Eterna Therapeutics all-time high quarterly accounts payable is $3.68 M
What is Eterna Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ERNA quarterly accounts payable has changed by +$729.00 K (+49.80%)